Selectis Health (GBCS) Cost of Revenue (2017 - 2025)
Selectis Health's Cost of Revenue history spans 9 years, with the latest figure at $7.0 million for Q4 2025.
- Quarterly results put Cost of Revenue at $7.0 million for Q4 2025, down 10.99% from a year ago — trailing twelve months through Dec 2025 was $31.8 million (up 4.61% YoY), and the annual figure for FY2025 was $31.8 million, up 4.61%.
- Cost of Revenue for Q4 2025 was $7.0 million at Selectis Health, down from $8.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $8.9 million in Q4 2021 to a low of $3.5 million in Q1 2021.
- The 5-year median for Cost of Revenue is $7.5 million (2024), against an average of $7.2 million.
- The sharpest move saw Cost of Revenue skyrocketed 96.4% in 2022, then dropped 11.85% in 2024.
- Year by year, Cost of Revenue stood at $8.9 million in 2021, then dropped by 2.18% to $8.7 million in 2022, then dropped by 10.66% to $7.7 million in 2023, then rose by 1.61% to $7.9 million in 2024, then dropped by 10.99% to $7.0 million in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods came in at $7.0 million, $8.5 million, and $8.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.